Physician

Hisham S. El-Kadi, MD

According to 2025 Medicare claims, Hisham El-Kadi, MD (NPI: 1184698466) practices rheumatology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is ARTHRITIS AND OSTEOPOROSIS ASSOCIATES (NPI: 1952356446; TIN: 223551184) and primary practice location at 07728-8307.

El-Kadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,102 traditional Medicare patients, billed 340,579 HCPCS/CPT codes, and received $3,513,190 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,641 prescription claims across 370 beneficiaries totaling $1,687,044 in drug costs, led by Enbrel Sureclick (Etanercept). 2017 DME data shows 11 claims. Open Payments data shows 46 records totaling $2,679. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,293	176,186	$3,300,773
2016	1,272	246,744	$4,027,095
2017	1,282	251,659	$3,635,871
2018	1,162	349,026	$4,598,789
2019	1,068	271,373	$4,192,849
2020	1,051	246,021	$3,517,026
2021	1,082	230,133	$3,300,507
2022	1,165	262,789	$3,282,068
2023	1,074	265,412	$3,276,161
2024	1,102	340,579	$3,513,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	679	2,824	$1,239,931
2016	675	3,004	$1,804,397
2017	627	2,951	$1,947,470
2018	572	2,485	$1,906,383
2019	615	2,391	$1,617,254
2020	609	2,550	$1,561,728
2021	490	2,237	$1,550,162
2022	444	1,991	$1,389,501
2023	407	1,973	$1,698,266
2024	370	1,641	$1,687,044

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$182
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	902	2,639	$107
20610	Aspiration and/or injection of fluid from large joint	297	722	$69
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	379	1,005	$62
J0897	Injection, denosumab, 1 mg	290	25,560	$20
J1010	Injection, methylprednisolone acetate, 1 mg	365	35,509	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	50	1,568	$415,461
Humira(Cf) Pen	Adalimumab	35	1,176	$351,657
Xeljanz Xr	Tofacitinib Citrate	33	1,050	$195,941
Rinvoq	Upadacitinib	15	510	$105,169
Benlysta	Belimumab	17	588	$67,082

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$856	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,823	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hisham S. El-Kadi, MD?

Tedicare shows public-source Medicare data for Hisham S. El-Kadi, MD (NPI 1184698466), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hisham S. El-Kadi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hisham S. El-Kadi, MD?

Hisham S. El-Kadi, MD is linked to ARTHRITIS AND OSTEOPOROSIS ASSOCIATES (billing NPI 1952356446) in the available physician profile data.

Does Hisham S. El-Kadi, MD have Open Payments data?

Hisham S. El-Kadi, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.